Skip to main content
Go to homepage

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer NCI-AHEP0731

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Description:

For complete study information, please visit clinicaltrials.gov.

Interested in participating?
We are currently recruiting
Full IRB Study Title:
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
IRB Study ID:
1038464 -1
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program